Gina Consylman, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 5,677 shares at $14.31 ($81K) on 2019-02-20, disclosed to the SEC on 2019-02-22.
Seasonal sale ($81k) by Chief Financial Officer — this insider has traded IRWD in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.31 | 318 | $5K | 5.6% |
| 2 | $14.31 | 1,119 | $16K | 19.7% |
| 3 | $14.31 | 1,957 | $28K | 34.5% |
| 4 | $14.31 | 2,237 | $32K | 39.4% |
| 5 | $14.32 | 2 | $29 | 0.0% |
| 6 | $14.32 | 9 |
| $129 |
| 0.2% |
| 7 | $14.32 | 17 | $243 | 0.3% |
| 8 | $14.32 | 18 | $258 | 0.3% |
| Total | $14.31 avg | 5,677 | $81K | 100% |
| Filing → |
| IRWD | SELL | 2020-02-25 | $217K | — | Filing → |
| IRWD | SELL | 2019-11-12 | $17K | — | Filing → |
| IRWD | SELL | 2019-08-20 | $2K | — | Filing → |